These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2879973)

  • 1. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.
    Ma DD; Scurr RD; Davey RA; Mackertich SM; Harman DH; Dowden G; Isbister JP; Bell DR
    Lancet; 1987 Jan; 1(8525):135-7. PubMed ID: 2879973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of P-glycoprotein in human leukemias using monoclonal antibodies.
    Mattern J; Efferth T; Bak M; Ho AD; Volm M
    Blut; 1989 Apr; 58(4):215-7. PubMed ID: 2565123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphoma.
    Mizuno Y; Hara T; Nagata M; Tawa A; Tsuruo T; Ueda K
    Eur J Pediatr; 1991 Apr; 150(6):416-8. PubMed ID: 1674913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype.
    List AF; Spier CM; Cline A; Doll DC; Garewal H; Morgan R; Sandberg AA
    Br J Haematol; 1991 May; 78(1):28-34. PubMed ID: 1675116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission.
    Musto P; Melillo L; Lombardi G; Matera R; di Giorgio G; Carotenuto M
    Br J Haematol; 1991 Jan; 77(1):50-3. PubMed ID: 1671821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies.
    Kartner N; Evernden-Porelle D; Bradley G; Ling V
    Nature; 1985 Aug 29-Sep 4; 316(6031):820-3. PubMed ID: 2412130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
    Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
    Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance in acute leukemia: a conserved physiologic function.
    List AF; Spier CM
    Leuk Lymphoma; 1992 Sep; 8(1-2):9-14. PubMed ID: 1283551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method.
    Volm M; Efferth T; Bak M; Ho AD; Mattern J
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):743-9. PubMed ID: 2565814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia.
    Ubezio P; Limonta M; D'Incalci M; Damia G; Masera G; Giudici G; Wolverton JS; Beck WT
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1895-9. PubMed ID: 2576650
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of P-glycoprotein expression in acute leukaemia as analysed by immunocytochemistry.
    Tiirikainen MI; Elonen E; Ruutu T; Jansson SE; Krusius T
    Eur J Haematol; 1993 May; 50(5):279-85. PubMed ID: 8100537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
    Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
    Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
    Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M
    Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia.
    Fenneteau O; Marie JP; Lescoeur B; Vilmer E; Schlegel N
    Blood; 1993 Dec; 82(12):3787-9. PubMed ID: 7903172
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
    Barrand MA; Twentyman PR
    Br J Cancer; 1992 Feb; 65(2):239-45. PubMed ID: 1346747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines.
    Capranico G; De Isabella P; Castelli C; Supino R; Parmiani G; Zunino F
    Br J Cancer; 1989 May; 59(5):682-5. PubMed ID: 2567607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia.
    Michieli M; Raspadori D; Damiani D; Geromin A; Gallizia C; Michelutti A; Fanin R; Fasola G; Russo D; Tazzari P
    Br J Haematol; 1991 Apr; 77(4):460-5. PubMed ID: 1673863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype.
    Webster L; Linsenmeyer M; Millward M; Morton C; Bishop J; Woodcock D
    J Natl Cancer Inst; 1993 Oct; 85(20):1685-90. PubMed ID: 8105099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.